JP2020519668A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519668A5
JP2020519668A5 JP2019563174A JP2019563174A JP2020519668A5 JP 2020519668 A5 JP2020519668 A5 JP 2020519668A5 JP 2019563174 A JP2019563174 A JP 2019563174A JP 2019563174 A JP2019563174 A JP 2019563174A JP 2020519668 A5 JP2020519668 A5 JP 2020519668A5
Authority
JP
Japan
Prior art keywords
mir
msc
pharmaceutical composition
aging
exogenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019563174A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2018/050538 external-priority patent/WO2018211510A1/en
Publication of JP2020519668A publication Critical patent/JP2020519668A/ja
Publication of JP2020519668A5 publication Critical patent/JP2020519668A5/ja
Pending legal-status Critical Current

Links

JP2019563174A 2017-05-16 2018-05-16 老化の阻害および老化関連障害の治療の方法 Pending JP2020519668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762506661P 2017-05-16 2017-05-16
US62/506,661 2017-05-16
PCT/IL2018/050538 WO2018211510A1 (en) 2017-05-16 2018-05-16 Methods of inhibiting aging and treating aging-related disorders

Publications (2)

Publication Number Publication Date
JP2020519668A JP2020519668A (ja) 2020-07-02
JP2020519668A5 true JP2020519668A5 (https=) 2021-07-26

Family

ID=64273428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019563174A Pending JP2020519668A (ja) 2017-05-16 2018-05-16 老化の阻害および老化関連障害の治療の方法

Country Status (6)

Country Link
US (2) US20200188440A1 (https=)
EP (1) EP3624817A4 (https=)
JP (1) JP2020519668A (https=)
AU (1) AU2018270408A1 (https=)
CA (1) CA3064064A1 (https=)
WO (1) WO2018211510A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3801028A4 (en) 2018-05-30 2022-04-13 Direct Biologics LLC A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use
CN108753779B (zh) * 2018-06-07 2021-12-14 天津农学院 牛lncRNA-133a及在牛骨骼肌卫星细胞增殖分化调控中的应用和验证方法
US20220177921A1 (en) * 2018-08-27 2022-06-09 BioViva USA, Inc. Gene therapy using genetically modified viral vectors
WO2020106997A1 (en) * 2018-11-21 2020-05-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for reducing age-related striated muscle and cognitive decline
US12569517B2 (en) * 2019-02-07 2026-03-10 Direct Biologics, Llc Method for treating osteoarthritis with mesenchymal stem cell exosomes
TWI722400B (zh) * 2019-03-18 2021-03-21 佛教慈濟醫療財團法人 間質幹細胞之胞外泌體及其用途
CN111218451B (zh) * 2020-02-05 2021-08-10 华中农业大学 一种提高猪肌肉量的方法
KR20230004709A (ko) 2020-04-22 2023-01-06 다이렉트 바이오로직스 엘엘씨 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물
KR102317052B1 (ko) * 2020-05-04 2021-10-25 주식회사 티에스셀바이오 태반 유래의 세포외 소포의 항염증 항바이러스 효과 조성물
CN111593114B (zh) * 2020-05-29 2022-12-20 广东医科大学附属医院 miR-122及其抑制剂在预防/治疗放射性脑损伤中的应用
JP6967308B1 (ja) * 2020-06-30 2021-11-17 国立大学法人高知大学 胎児付属物由来組織細胞培養上清を含む脳神経障害治療剤
CN112280742A (zh) * 2020-11-05 2021-01-29 北京欣颂生物科技有限公司 干细胞制备的抗衰老的药物组合物或者保健品
CN112089733B (zh) * 2020-11-05 2021-03-12 广东赛尔生物科技有限公司 一种改造的脐带干细胞在制备抗衰老的药物组合物或者保健品中的用途
WO2022102784A1 (ja) * 2020-11-16 2022-05-19 ヒューマンライフコード株式会社 筋肉量の低下抑制に用いる細胞調製物
WO2022170056A1 (en) * 2021-02-05 2022-08-11 BioViva USA, Inc. Systems and methods for gene therapy via administration of genetically modified viral vectors
KR102523933B1 (ko) * 2021-05-03 2023-04-20 고려대학교 산학협력단 융모막 추출물로부터 분리된 엑소좀을 유효성분으로 포함하는 골형성 촉진용 약학적 조성물
CN113981074A (zh) * 2021-12-10 2022-01-28 石河子大学 一种与2型糖尿病相关的microRNA及其应用
JP2023167026A (ja) * 2022-05-11 2023-11-24 克昭 團 膵機能活性化剤、抗老化剤、２型糖尿病の治療薬または予防薬、医薬品、化粧品および食品または飲料
CN115044543A (zh) * 2022-08-17 2022-09-13 山东卓东生物科技有限公司 一种提高衰老人体来源肌肉干细胞活性的方法
CN116926072B (zh) * 2023-05-04 2024-03-08 广州飞来爱生命科技有限公司 一种抑制神经干细胞诱导分化方法及其应用
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8192988B2 (en) * 2004-10-22 2012-06-05 University Of Central Florida Research Foundation, Inc. Methods for increasing potency of adult mesenchymal stem cells
KR20120096793A (ko) * 2011-02-23 2012-08-31 (주)차바이오앤디오스텍 태반 유래 줄기세포를 포함한 면역반응억제용 조성물
WO2013124817A2 (en) * 2012-02-22 2013-08-29 Brainstem Biotec Ltd. MicroRNAS FOR THE GENERATION OF ASTROCYTES
KR101555981B1 (ko) * 2013-05-01 2015-09-30 차의과학대학교 산학협력단 태반 유래 중간엽 줄기 세포, 또는 태반 유래 줄기세포로부터 유도된 신경 전구세포, 이를 포함하는 약학적 조성물, 질환 치료용 키트, 및 이를 이용하는 질환 치료방법
EP3004328A4 (en) * 2013-05-30 2016-12-07 Cells For Cells MESENCHYMAL STEM CELLS OF CHORIONIC ORIGIN, CONDITIONED MEDIUM AS AN ANGIOGENESIS INDUCER AND USE THEREOF FOR TREATMENT OF CARDIAC DEGENERATION
EP3140417B1 (en) * 2014-05-09 2021-04-21 Reelabs Private Limited Foetal polymix of mesenchymal stem cells under hypoxic conditions for the treatment of clinical disorders
WO2016057755A1 (en) * 2014-10-09 2016-04-14 Anthrogenesis Corporation Placenta-derived adherent cell exosomes and uses thereof
CN104560869B (zh) * 2014-12-18 2018-02-23 江苏省北科生物科技有限公司 一种制备绒毛膜间充质干细胞的方法
US20160324898A1 (en) * 2015-05-04 2016-11-10 Stemedica International, Sa Compositions and methods for the treatment of alzheimer's disease
JP2019514416A (ja) * 2016-05-16 2019-06-06 エグゾステム バイオテック リミテッド 間葉系幹細胞と筋損傷及び筋肉関連疾患の治療のための間葉系幹細胞の使用
KR20190109389A (ko) * 2016-11-03 2019-09-25 엑소스템 바이오텍 리미티드 간엽 줄기 세포 집단, 이들의 산물 및 이들의 용도

Similar Documents

Publication Publication Date Title
JP2020519668A5 (https=)
US20240173354A1 (en) Methods of inhibiting aging and treating aging-related disorders
US12150963B2 (en) Mesenchymal stem cell and use thereof for treatment of muscle injury and muscle-associated diseases
US12053493B2 (en) Mesenchymal stem cells populations, their products, and use thereof
ES2705052T3 (es) Micropartículas de células madre y ARNmi
WO2012065027A3 (en) Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases
US20180312839A1 (en) Methods and compositions for increasing smn expression
BR112016013516A8 (pt) complexo de transfecção e seu uso para aumentar transporte de molécula de carga em células e para o tratamento de câncer e terapia gênica, bem como método in vitro para fornecer um poliânion a uma célula
JP2011522036A5 (https=)
WO2011130458A3 (en) Rna aptamers against baff-r as cell-type specific delivery agents and methods for their use
Brusa et al. Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives
Liu et al. Enhancing the efficiency of direct reprogramming of human primary fibroblasts into dopaminergic neuron-like cells through p53 suppression
WO2024192277A2 (en) Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents
RU2021135194A (ru) Способы и аппараты для подготовки клеточных популяций для клеточной терапии
Cai et al. Non-coding RNAs steering the senescence-related progress, properties, and application of mesenchymal stem cells
German et al. Retina stem cells, hopes and obstacles
JP2014515258A5 (https=)
AU2020101933A4 (en) Methods and compositions for preventing or treating heart disease
Wu et al. Can pluripotent/multipotent stem cells reverse Parkinson’s disease progression?
JP2016510808A5 (https=)
Birbrair Molecular players in iPSC technology
US20190055553A1 (en) Methods for identifying and targeting non-coding rna scaffolds
KR101927073B1 (ko) 메트포민 전처리를 통한 중간엽 줄기세포의 신경세포로의 분화율 및 신경돌기 성장을 촉진시키는 방법
EP4386384A1 (en) Potency assay for pharmaceutical products
WO2021035391A1 (zh) 转运rna分子及其片段用于预防或治疗心脏疾病的用途